Janus Kinase Inhibitors: A Next Generation Treatment in Dermatology
March 2022
in “
Journal of Pakistan Association of Dermatologists
”
Studysummary This article reviews the mode of action, efficacy, and safety of Janus kinase inhibitors in autoimmune dermatological conditions but reports no new clinical results.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jpad.com.pk →